Skip to main content

Table 1 Characteristics of considered approaches (% of all studies)

From: Cancer screening simulation models: a state of the art review

Characteristic Individual level Cohort level Regression DE Other
Breast cancer 25 (10%) 25 (10%) 6 (2%) 2 (1%) 12 (5%)
Cervical cancer (all) 19 (7%) 49 (19%) 8 (3%) 5 (2%) 8 (3%)
Cervical cancer (no prevention) 6 (2%) 21 (8%) 5 (2%) 0 (0%) 4 (2%)
Colorectal cancer 30 (11%) 25 (10%) 5 (2%) 2 (1%) 3 (1%)
Lung cancer 11 (4%) 8 (3%) 0 (0%) 1 (0%) 6 (2%)
Prostate cancer 14 (5%) 5 (2%) 4 (2%) 1 (0%) 6 (2%)
Avg. Quality 4.5 4.1 3.7 4.4 4.1
Application 83 (32%) 105 (40%) 20 (8%) 11 (4%) 26 (10%)
Development 16 (6%) 75 (29%) 17 (6%) 7 (3%) 10%)
  1. Note that the percent sum can be greater than 100%, because all characteristics are not mutually exclusive (e.g. a study on breast and lung cancer that exploits both an ILMs and a CLMs simultaneously)